Shares of GH Research (GHRS) climbed ~20% in the post-market trading after the psychiatric drug developer announced plans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback